Our data demonstrate the ability of anti‐CD19 CAR to drive efficient activation of CAR‐NK cells in the presence of CD19‐expressing target cells such as the Nalm6 cell line, leading to a large increase in the expression of anti‐tumor cytokines as well was chemokines which are necessary for an effective immune recruitment cascade. This evidence concerns the gene CD19 and neoplasm.